Abstract
Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib–IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y and Sugimachi K (2000) Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Brit J Cancer 83: 887–891
André T, Kotelevets L, Vaillant JC, Coudray AM, Weber L, Prévot S, Parc R, Gespach C and Chastre E (2000) VEGF, VEGF-B, VEGF-C, and their receptors KDR, Flt-1 and flt-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86: 174–181
Bunone G, Vigneri P, Mariani L, Butó S, Collini P, Pilotti S, Pierotti MA and Bongarzone I (1999) Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155: 1967–1976
Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I and Yajima A (1994) Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 54: 3922–3928
Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PAE, Harris AL and Fox SB (2000) The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6: 4278–4286
Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N and Alitalo K (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16: 3898–3911
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Beitman M and Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566–3570
Kodama J, Yoshinouchi M, Seki N, Hongo A, Miyagi Y and Kudo, (1999a) Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer. Int J Oncol 15: 149–154
Kodama J, Seki N, Tokumo A, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H and Kudo T (1999b) Vascular endothelial growth factor is implicated in early invasion of cervical cancer. Eur J Cancer 35: 485–489
Kukk E, Lymboussaki A, Taira S, Kaipanen A, Jeltsch M, Joukov V and Alitalo K (1996) VEGF-C receptor binding, and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829–3837
Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S and Sonoo H (1999) Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 90: 977–981
Lurain JR (1996). Uterine cancer. In: Novaks Gynecology, Berek JS (ed) pp 1057–1110. Williams and Wilkins: Maryland
Maglione D, Guerriero V, Viglietto G, Delli-Bovi P and Persico MG (1991) Isolation of a human placental cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267–9271
Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ and Dehio C (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18: 363–374
Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y and Hirohashi S (2000) Expression of vascular endothelial growth factor A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 2431–2439
Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y and Pass HI (1999) VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Brit J Cancer 81: 54–61
Olofsson B, Pajusola K, Kaipanen A, von Euler G, Joukov V, Saksela O, Orpana A, petterson RF, Alitalo K and Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93: 2576–2581
Scheidler J, Hricak H, Yu KK, subak L and Segal MR (1997) Radiological evaluation of lymph node metastases in patients with cervical cancer. A mete-analysis. JAMA 278: 1096–1101
Seki A, Kodama J, Miyagi Y, Kamimura S, Yoshinouchi M and Kudo T (1997) Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas. Int J Cancer 73: 33–37
Tsurusaki T, Kanda S, Sasaki H, Kanetake H, Saito Y, Alitalo K and Koji T (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Brit J Cancer 80: 309–313
Valtola R, Salven P, Heikkilä P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, de Waal R and Alitalo K (1999) VEGFR-3 and its ligand VEGF-Care associated with angiogenesis in breast cancer. Am J Pathol 154: 1381–1390
Yamada Y, Nezu J, Shimane M and Hirata Y (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42: 483–488
Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K and Sasaki T (1999) Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5: 1823–1829
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hashimoto, I., Kodama, J., Seki, N. et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 85, 93–97 (2001). https://doi.org/10.1054/bjoc.2001.1846
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1846
Keywords
This article is cited by
-
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Journal of Cancer Research and Clinical Oncology (2022)
-
A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma
Journal of Translational Medicine (2020)
-
The Role of Perioperative Pharmacological Adjuncts in Cancer Outcomes: Beta-Adrenergic Receptor Antagonists, NSAIDs and Anti-fibrinolytics
Current Anesthesiology Reports (2015)
-
VEGF targets the tumour cell
Nature Reviews Cancer (2013)
-
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB
Journal of Cancer Research and Clinical Oncology (2012)